Symposium abstracts:
Lamberton, G.R.1, Pereau, M. 1, Illes, K. 2, Kelly, I.L. 1, Childers, B.J. 3, Oberg, K.C, 1,3, Szalay, A.A.2
(1) Department of Pathology & Human Anatomy
(2) Department of Biochemistry
(3) Department of Surgery
Loma Linda University, Loma Linda, CA. 92350, USA. Email: koberg@som.llu.edu
Introduction: S. pyogenes is a common Gram-positive organism
found in the nasopharynx that can cause severe systemic and invasive disease.
The development of a bioluminescent strain of S. pyogenes would aid in
the study of disease progression.
Methods: Two strains of S. pyogenes were transformed with a Gram-positive
plasmid, pDC123, containing a modified luciferase fusion gene, LuxF in
front of the constitutive tetracycline promoter (PtetM). A Gram-positive ribosomal
binding site was attached to the five prime end of the LuxF gene to allow
for efficient translation in S. pyogenes. This new construct (pDC123/LuxF)
was then electroporated into competent bacteria and transformants were grown
on blood agar plates. Bioluminescence was characterized following exposure to
the substrate decyl-aldehyde on culture plates and following subcutaneous injections
into mice.
Results: Electroporation was successful in transforming both strains of S.
pyogenes. Bioluminescence was first detected with 105 colonies
of S. pyogenes and then linearly correlated between 106 and 108.
Detection of subcutaneous bioluminescence was about 10 fold less than on culture
plates.
Conclusions: These findings demonstrate that it is possible to transform strains
of S. pyogenes. Furthermore, generation of a bioluminescent strain of
S. pyogenes may allow for precise monitoring of bacterial colonization, infection
and disease progression in vivo.
This
is a preprint of an article accepted for publication in Luminescence: Copyright
2001 John
Wiley & Sons, Ltd (Wiley website)